untitled
viviti

Solitary pulmonary nodule. Postgraduate medicine: classifying solitary pulmonary nodules. Medlineplus medical encyclopedia: solitary pulmonary nodule.

Emedicine - solitary pulmonary nodule : article by sanjay manocha, md.

Solitary pulmonary nodule- pulmonologychannel

Solitary pulmonary nodule. A, neurofibroma, blastoma, sarcoma, lung abscess, round pneumonia, hydatid cyst, rheumatoid arthritis, RA, Wegener granulomatosis, sarcoidosis, lipoid pneumonia, arteriovenous malformation, AVM, lung cyst, pulmonary infarct, round atelectasis, mucoid impaction, mucus impaction, progressive massive fibrosis   AUTHOR INFORMATION Section 1 of 10 Author Information Introduction Clinical Differentials Workup Treatment Follow-up Miscellaneous Pictures Bibliography Author: Sat Sharma, MD, FRCPC, FACP, FCCP, DABSM, Program Director, Associate Professor, Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Manitoba; Site Director of Respiratory Medicine, St Boniface General Hospital Coauthor(s): Sri R Navaratnam, MBBS, FRCPC, PhD, Assistant Professor, Department of Internal Medicine, Section of Hematology Medical Oncology, University of Manitoba; Medical Oncologist, Department of Hematology Oncology, CancerCare Manitoba Sat Sharma, MD, FRCPC, FACP, FCCP, DABSM, is a member of the following medical societies: American Academy of Sleep Medicine, American College of Chest Physicians, American College of Physicians-American Society of Internal Medicine, American Thoracic Society, Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, Royal Society of Medicine, Society of Critical Care Medicine, and World Medical Association Editor(s): Stephen P Peters MD, PhD, Professor, Department of Medicine, Wake Forest University; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Robert S Crausman, MD, MMS, solitary pulmonary		  

Postgraduate medicine: lung cancer symposium: management of ...

Ation: Upper Middle Lower Edge: Smooth Lobulated Spiculated Growth Rate: Not Known Benign Malignant Cavity Wall Thickness: Not cavitated < 4 mm 5-15 mm >16 mm Calcification: None Benign Pattern Additional Characteristics Contrast Enhancement: Not Performed < 15 HU > 15 HU PET: Not Performed SUR < 2.5 SUR > 2.5 The Probability of Malignancy is: Likelihood Ratios 20-29 0.05 30-39 0.24 40-49 0.94 50-59 1.90 60-69 2.64 Nonsmoker 0.15 < 30 pk-yrs 0.74 30-39 pk-yrs 2 >40 pk-yrs 3.7 Hemoptysis, absent 1 Hemoptysis, present 5.08 No prev malig 1 Prev Malig 4.95 0-1 cm 0.52 1.1 - 2.0 0.74 2.1 - 3.0 3.67 > 3.0 cm 5.23 upper middle 1.22 Lower 0.66 Smooth 0.3 Lobulated 0.74 Spiculated 5.54 Growth, not known 1 Benign growth rate 0.01 Malignant growth rate 3.4 Not cavitated 1 < 4 mm 0.07 5 - 15 mm 0.72 > 16 38 Not calcified 2.2 Benign calcification 0.01 Enhancement < 15 HU 0.04 Enhancement > 15 HU 2.32 SUR < 2.5 0.06 SUR > 2.5 7.1 Probability of Malignancy in SPN: Logistic Regression Compare the above result to this method derived from multivariate logistic regression in 629 patients (65% benign, 23% malignant, 12% indeterminate). The equation is based on 3 clinical and 3 radiographic variables. Probability of Malignancy = ex(1 + ex) where x = -6.8272 + (0.0391 * Age) + (0.7917 * Cigarettes) + (1.3388 * Cancer) + (0.1274 * Diameter) + (1.0407 * Spiculation) + (0.7838 * Upper). Note: this equation is not applicable to patients with a diagnosis of cancer that has been made within the previous 5 years or to patients with previous lung cancer. Refe solitary pulmonary


| Pulmonary circuit | Alexisonfire pulmonary archery | Pulmonary contusion | Hypertrophic pulmonary osteoarthropathy | Pulmonary wedge pressure | Pulmonary aneurism | Multiple pulmonary nodules |

[ Pulmonary ]
solitary pulmonary nodule News:
Des of Recommendations and Estimates of Net Benefit The grade of the strength of recommendations is based on both the quality of the evidence and the net benefit of the service (i.e., test, procedure, etc). Grade A The panel strongly recommends that clinicians routinely provide the service to eligible patients. An "A" recommendation indicates good evidence that the service improves important health outcomes and that benefits substantially outweigh harms. Grade B The panel recommends that clinicians routinely provide the service to eligible patients. A "B" recommendation indicates at least fair evidence that the service improves important health outcomes and concludes that benefits outweigh harms. Grade C The panel recommends that clinicians routinely provide the service to eligible patients. A "C" recommendation indicates that there was consensus among the panel to recommend the service but that the evidence that the service is effective is lacking, of poor quality, or conflicting, or

solitary pulmonary nodule An active inflammatory process solitary pulmonary nodule, and this diagnostic modality is not generally available. If a period of observation is chosen solitary pulmonary nodule, chest x-rays solitary pulmonary nodule, and possibly serial CT scans solitary pulmonary nodule, should be done at 3-month intervals over at least a two year period to determine if any change in the size of the nodule has occurred. An increase in the diameter of the nodule by 25% indicates a doubling of the mass volume. When to Refer Once the decision has been made that the patient& 8217;s SPN may represent a malignancy solitary pulmonary nodule, a histologic diagnosis is needed. If the patient& 8217;s SPN has characteristics strongly suggesting malignancy solitary pulmonary nodule, and there are no contraindications to surgery solitary pulmonary nodule, refer to a thoracic surgeon. In most other circumstances refer to a pulmonologist for further workup. Diagnostic procedures may include: fiberoptic bronchoscopy aided by fluoroscopy solitary pulmonary nodule, or CT-guided transthoracic fine needle aspiration. The yield of these procedures in the diagnosis of the small solitary pulmonary nodule (< 1.5 cm in diame solitary pulmonary nodule.

solitary pulmonary nodule To 75% of solitary pulmonary nodules are metachronous primary lung carcinomas solitary pulmonary nodule, and 58% in patients with a history of carcinoma of the bladder solitary pulmonary nodule, breast solitary pulmonary nodule, cervix solitary pulmonary nodule, bile duct solitary pulmonary nodule, esophagus solitary pulmonary nodule, ovary solitary pulmonary nodule, prostate solitary pulmonary nodule, or stomach are malignant (12). In addition solitary pulmonary nodule, patients with a history of melanoma solitary pulmonary nodule, sarcoma solitary pulmonary nodule, or testicular carcinoma are more likely to have a metastasis presenting as a solitary pulmonary nodule (12). The risk of a second primary cancer is 1% to 2% per patient per year for patients who have survived non-small cell lung cancer and 6% per patient per year for those who have survived small cell lung cancer (13). Another patient factor that increases the likelihood of cancer solitary pulmonary nodule, especially when combined with cigarette smoking solitary pulmonary nodule, is a history of exposure to asbestos solitary pulmonary nodule, radiation solitary pulmonary nodule, or radon. On the other hand solitary pulmonary nodule, a history of exposure to tuberculosis solitary pulmonary nodule, travel to an area endemic for fungal infection solitary pulmonary nodule, or a history of inflammatory connective tissue disease such as rheumatoid arthritis suggests a benign origin for .

solitary pulmonary nodule Ng precise calculations solitary pulmonary nodule, physicians can estimate the probability of cancer by assessing predictor variables in a given situation. The presence of certain criteria can be used to guide strategy choices. For example solitary pulmonary nodule, if the patient is a young (<40 years) nonsmoker with a small (<1.5 cm in diameter) nodule that has sharp solitary pulmonary nodule, smooth edges solitary pulmonary nodule, the probability of cancer is less than 5%. In this circumstance solitary pulmonary nodule, decision-analysis studies suggest that the most effective management strategy is prospective determination of stability through serial chest films (6). In an older smoker with a large nodule that has spiculated margins solitary pulmonary nodule, the probability of cancer is very high solitary pulmonary nodule, and immediate thoracotomy is usually the procedure of choice. Table 1. Variables predicting whether a solitary pulmonary nodule is benign or malignant Favoring benignity Favoring malignancy Age < 48 yr Age > 48 yr Age < 30 yr* (LR = 0.11) Age > 65 yr* (LR = 3.2) Nodule diameter < 1.5 cm Nodule diameter > 1.5 cm Nev.

solitary pulmonary nodule solitary pulmonary
solitary pulmonary nodule | | | | | |
solitary pulmonary nodule That cause SPNs, the percentage of benign SPNs increases remarkably (in some areas as high as 90% to 95%). Malignant SPNs may be primary Stage I lung cancer tumors or metastases from other parts of the body. Determining the malignancy of an SPN is an integral and challenging part of diagnosis. One of the goals of diagnosis is to avoid unnecessary invasive procedures, such as surgically removing part of the lung because of a benign SPN. Benign SPNs can be treated in simpler, noninvasive ways. Risk Factors There is always the chance that a nodule on a chest x-ray is malignant (i.e., cancerous). SPNs should be considered potentially cancerous until proven otherwise. Risk factors that increase the chance that a nodule is malignant include: a history of cigarette smoking (some researchers include marijuana smoking as well, but the evidence is controversial); age older than 45 years; male; presence of respiratory symptoms; and a history of cancer elsewhere in the body. Factors that increase




Web Hosting · Blog · Guestbooks · Message Forums · Mailing Lists
Easiest Website Builder ever! · Build your own toolbar · Free Talking Character · Email Marketing
powered by a free webtools company bravenet.com